MiMedx (MDXG) placental “stem cell magnet” drugs attract FDA attention and lawsuit
ABC News just reported that the FDA is allgedly “cracking down” on the publicly traded company, MiMedx (MDXG), which sells a placental derivative touted for healing powers. The Wall Street Journal is also following the story. According to ABC News: MiMedx is a publically traded, for-profit company that takes donated human placentas — solicited via a website featuring […]
MiMedx (MDXG) placental “stem cell magnet” drugs attract FDA attention and lawsuit Read More »